Table 7.
Multivariate analysis results for DFS
| Multivariate Model (all pts: 180) | N patients | N events | HR | 95% CI low | 95% CI high | p-value |
|---|---|---|---|---|---|---|
| Germline (positive vs. negative) | 45 vs. 135 | 11 vs. 37 | 0.514 | 0.115 | 2.301 | 0.384 |
| TP53 (MUT vs. nonMUT) | 106 vs. 74 | 29 vs. 19 | 0.821 | 0.426 | 1.581 | 0.555 |
| Germline* TP53 MUT status# | 0.053^ | |||||
| Germline positive; TP53 MUT vs. WT | 24 vs. 21 | 9 vs. 2 | 3.34 | 0.615 | 18.125 | |
| Germline negative; TP53 MUT vs. WT | 82 vs. 53 | 20 vs. 17 | 0.847 | 0.439 | 1.636 | |
| Menopausal status (post vs. pre) | 89 vs. 91 | 20 vs. 28 | 0.694 | 0.379 | 1.272 | 0.238 |
| Tumor size (>2 vs. ≤2) | 107 vs. 73 | 34 vs. 14 | 1.465 | 0.756 | 2.839 | 0.257 |
| Number of positive nodes (≥4 vs. 0-3) | 41 vs. 139 | 20 vs. 28 | 3.78 | 1.999 | 7.145 | <0.001 |
| Adjuvant Radiotherapy (yes vs. no) | 134 vs. 46 | 31 vs. 17 | 0.486 | 0.257 | 0.918 | 0.026 |
| TILs (continuous, 10% increments) | n.a. | n.a. | 0.769 | 0.624 | 0.948 | 0.014 |
Interaction between germline status and tumor TP53 mutations;
Likelihood ratio test for interaction;
Interaction (statistical);
HR: Hazard ratio; N.a.: Not applicable for continuous variables; Significant results are shown in bold.